NFKB1 and hepatocellular carcinoma: Additionally, miR-195 reduces the expression of multiple NF-κB downstream effectors by directly targeting IKKα and TAB3 in hepatocellular carcinoma (HCC) [28] and inhibits an M1-like polarization-induced proinflammatory profile in macrophages [29].